Pilot Study to Evaluate a Noninvasive Electrocardiographic Monitoring Strategy Associated With Early Discharge in Patients With Conduction Disorders Following TAVI Implantation (IMPROVE Study)

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 100 participants.

Also called NCT07456280

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose other
Phase
Not applicable
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07456280
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Spain (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07456280. Randomized; no masking; primary purpose other. Start 2026-07-20 (actual); primary completion 2028-07-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Pilot Study to Evaluate a Noninvasive Electrocardiographic Monitoring Strategy Associated With Early Discharge in Patients With Conduction Disorders Following TAVI Implantation (IMPROVE Study)
Acronym
IMPROVE
Condition
Severe Aortic Valve Stenosis
Condition
Cardiovascular Diseases
Intervention (Behavioral)
Standard care
Intervention (Device)
PhysioMem PM 100 4G ambulatory monitoring system
Lead sponsor
Hospital Universitari Vall d'Hebron Research Institute (class: other)

Record details

Record id
cardio:ct-nct07456280
Content hash
8c89c3d1450e7d200f53828536401e3a61fddf72db435ab67e927c9f3f1dbdfe